Alto Neuroscience Inc (ANRO)
4.81 +0.29 (+6.42%) 14:36 ET [NYSE]
4.78 x 400 4.82 x 300
Realtime by (Cboe BZX)
4.78 x 400 4.82 x 300
Realtime - - (-) -
for Thu, Jan 23rd, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
Operating Expenses | 18,886 | 18,341 | 14,386 | 11,765 | 9,718 |
Operating Income | -18,886 | -18,341 | -14,386 | -11,765 | -9,718 |
Interest Expense | 349 | 347 | 346 | 356 | 363 |
Other Income | 2,452 | 2,658 | 1,315 | 904 | 940 |
Pre-tax Income | -16,783 | -16,030 | -13,417 | -11,217 | -9,141 |
Net Income Continuous | -16,783 | -16,030 | -13,417 | -11,217 | -9,141 |
Net Income | $-16,783 | $-16,030 | $-13,417 | $-11,217 | $-9,141 |
EPS Basic Total Ops | -0.62 | -0.60 | -0.76 | -2.99 | -2.44 |
EPS Basic Continuous Ops | -0.62 | -0.60 | -0.76 | -2.98 | -2.44 |
EPS Diluted Total Ops | -0.62 | -0.60 | -0.76 | -2.99 | -2.44 |
EPS Diluted Continuous Ops | -0.62 | -0.60 | -0.76 | -2.98 | -2.44 |
EPS Diluted Before Non-Recurring Items | N/A | -0.60 | -0.76 | N/A | N/A |
EBITDA(a) | $-18,764 | $-18,228 | $-14,289 | $-11,653 | $-9,655 |